Wednesday, July 8, 2026

pharma · Fatty Liver · Inflammatory Disease · GLMD

Galmed Pharmaceuticals

Galmed Pharmaceuticals drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

16 Ze’ev Tiomkin Street, Tel Aviv, 6578317, IL, USA HQ
2000 Founded
10 Employees
Public company Type
GLMD · NYSE Ticker
Company details
Status
Public
HQ
16 Ze’ev Tiomkin Street, Tel Aviv, 6578317, IL, USA
Founded
2000
Employees
10
Programs
13
Drugs
5
Patents
11
Intelligence · Drug Pipeline

Galmed Pharmaceuticals pipeline

Portfolio lens on 5 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Galmed Pharmaceuticals drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

5 compounds
  1. US regulatory status: approved.

  2. Development asset linked to Galmed Pharmaceuticals in public FDA and regional records.

  3. Development asset linked to Galmed Pharmaceuticals in public FDA and regional records.

  4. Development asset linked to Galmed Pharmaceuticals in public FDA and regional records.

  5. Development asset linked to Galmed Pharmaceuticals in public FDA and regional records.